Browse the evidence

The accumulation of senescent cells and their Secretory Phenotype (SASP) drives chronic inflammation (inflammaging) and contributes to age-related tissue dysfunction.

Chronic low-grade inflammation is a key driver of aging. Research suggests that this inflammation is partly caused by the accumulation of senescent cells. Therapies that clear these cells have been shown to reduce inflammatory markers in animal models.

Elevated plasma levels of asymmetric dimethylarginine (ADMA) impair endothelial function by competitively inhibiting nitric oxide synthase, leading to reduced vasodilation in hypercholesterolemic individuals.

If you have high cholesterol, your body may produce more ADMA, a substance that blocks blood vessel relaxation. This happens even before symptoms appear. Administering L-arginine can reverse this blockage and restore normal blood flow, suggesting that managing cholesterol is critical to preventing this specific biochemical imbalance.

Pharmacological administration of cholecystokinin (CCK) reduces meal size acutely in humans and animals, but chronic administration fails to produce sustained weight loss due to compensatory increases in meal frequency.

While CCK reduces meal size when given, the body compensates by eating more often, so it doesn't help with long-term weight loss. This highlights why simply trying to 'stop eating' with one-off interventions often fails.

Activation of PPARγ by synthetic thiazolidinediones (glitazones) improves insulin sensitivity and reduces blood glucose in type 2 diabetes, but carries significant cardiovascular risks (e.g., rosiglitazone) and side effects (weight gain, edema).

If prescribed a PPARγ agonist for diabetes, understand that while they improve insulin sensitivity, the specific drug matters. Pioglitazone may offer cardiovascular benefits, whereas rosiglitazone has been linked to increased heart risks. Discuss side effects like weight gain and edema with your doctor.

Preoperative identification of Obstructive Sleep Apnea (OSA) via clinical criteria improves perioperative outcomes by enabling tailored airway management, even in the absence of formal sleep studies.

If you have risk factors for sleep apnea (high BMI, large neck, snoring), tell your anesthesiologist before surgery. This allows them to prepare for potential airway issues, significantly reducing your risk of complications, even if you feel healthy.

Dietary omega-3 polyunsaturated fatty acids (specifically EPA) combined with aspirin or other NSAIDs generate novel anti-inflammatory lipid mediators (18R-HEPE, 5,12,18R-triHEPE, and 15-epi-LXA5) via transcellular processing involving COX-2 and leukocyte 5-lipoxygenase, which inhibit polymorphonuclear leukocyte (PMN) transendothelial migration and infiltration.

If you take omega-3 supplements (specifically EPA) and have inflammation (which upregulates COX-2), your body can convert these fats into potent anti-inflammatory signals, especially if you take aspirin or certain other NSAIDs. These signals actively stop immune cells from migrating to inflamed tissues. This suggests that the benefit of omega-3s is not just passive competition but active creation of anti-inflammatory mediators.

Overtraining syndrome (OTS) is diagnosed retrospectively through the exclusion of organic diseases and other stressors, as no single diagnostic marker currently exists to definitively identify it.

If you are an athlete experiencing prolonged performance decline and fatigue, do not look for a single 'overtraining test.' Instead, work with medical professionals to rule out other causes like anemia, thyroid issues, or infections. Focus on identifying and managing non-training stressors (sleep, life stress) and ensuring adequate nutrition, as these are key contributors to the syndrome.

Basal (resting) hormone measurements, including cortisol and testosterone/cortisol ratios, are not useful for diagnosing overtraining syndrome or distinguishing between well-adapted and overtrained athletes.

Do not rely on resting blood tests for testosterone or cortisol to diagnose overtraining. These levels are influenced by many factors and do not reliably distinguish between healthy adaptation and overtraining. Focus on performance metrics and subjective feelings of fatigue.

Roux-en-Y gastric bypass (RYGB) surgery induces rapid, starvation-like adaptations in gut microbiota composition, specifically increasing Bacteroides/Prevotella and E. coli while decreasing Lactobacillus and Bifidobacterium, which correlates with reduced body fat and leptin levels independently of caloric intake for some species.

Bariatric surgery like RYGB triggers a rapid reorganization of gut bacteria that mirrors a starvation response, helping to reduce body fat and inflammation. This happens partly because the surgery changes gut pH and bile flow, not just because you eat less. For obese individuals, this microbial shift is a key part of why metabolic health improves so quickly after surgery.

Inhibiting the inflammatory enzyme JNK in the hypothalamus restores insulin signaling, reduces caloric intake, and promotes weight loss in subjects consuming a high-fat diet.

This study used a specific drug (SP600125) to block an inflammatory enzyme in the brain of rats. While this restored weight loss, this is a research tool and not a recommended supplement for humans. The finding suggests that managing brain inflammation might be key to treating obesity.

Surgery-induced weight loss in morbidly obese subjects significantly reduces the number of macrophages infiltrating subcutaneous white adipose tissue (scWAT) and shifts their phenotype from pro-inflammatory to anti-inflammatory (IL10-positive).

For morbidly obese individuals, significant weight loss (achieved here via surgery) actively reduces inflammation in fat tissue. It doesn't just remove fat; it changes the immune environment of the fat, turning harmful inflammatory cells into less harmful ones. This suggests that weight loss has direct anti-inflammatory benefits beyond just lowering body weight.

Weight loss reduces the expression of genes involved in macrophage recruitment (MCP-1, CSF-3, PLAUR) and hypoxia (HIF-1) in the stroma vascular fraction of white adipose tissue.

Obesity causes fat tissue to produce signals (like MCP-1 and HIF-1) that attract inflammatory cells. Losing weight reduces these signals, thereby stopping the recruitment of new inflammatory cells to fat tissue.

Long-term exposure to rotating night shifts (≥30 years) is associated with a statistically significant increase in breast cancer risk in women, primarily mediated by the suppression of melatonin due to nighttime light exposure.

If you work rotating night shifts, especially for many years, your risk of breast cancer may be moderately higher. This is likely because light at night suppresses melatonin, a hormone that may protect against cancer. While you may not be able to change your job, consider strategies to minimize light exposure during night hours (like wearing an eye mask) and discuss your work history with your doctor to ensure appropriate screening.

Chronic low-grade inflammation (inflammaging) is a key pathophysiologic association in aging, driven by oxidative stress-induced redox imbalance and the accumulation of senescent cells.

Recognize that chronic, low-grade inflammation is a key driver of aging. Strategies to reduce inflammation, such as managing stress, maintaining a healthy weight, and ensuring adequate sleep, may help mitigate age-related degeneration.

Skin pigmentation (melanin) acts as a natural sunscreen, reducing the efficiency of cutaneous vitamin D3 synthesis, requiring darker-skinned individuals to have longer sun exposure to achieve similar vitamin D levels as lighter-skinned individuals.

If you have darker skin, you may need more time in the sun to produce adequate vitamin D compared to those with lighter skin. Consider this when evaluating your sun exposure habits.

Dietary fiber fermentation by gut microbiota produces short-chain fatty acids (SCFAs) which activate specific receptors (GPR41, GPR43, GPR109A) to regulate energy expenditure, lipid homeostasis, and inflammation.

Prioritize diverse sources of dietary fiber to support gut bacteria that produce SCFAs. These microbial byproducts act as signals to regulate your metabolism and reduce inflammation, offering benefits beyond simple caloric intake.

Non-caloric artificial sweeteners (NAS) induce glucose intolerance by altering gut microbiota composition, and these effects can be reversed by antibiotics.

Be cautious with non-caloric artificial sweeteners, as they may negatively impact glucose tolerance by altering your gut microbiome. Opt for whole foods or unsweetened beverages when possible.

AMPK activation prevents cancer initiation and promotion by suppressing chronic inflammation and anabolic pathways, but may promote progression and metastasis in established tumors by enabling metabolic adaptation.

For cancer prevention, maintaining metabolic health through exercise and diet (which activate AMPK) is beneficial. However, for individuals with existing cancer, the role of AMPK is complex and may support tumor survival; therefore, any metabolic interventions should be discussed with an oncologist, as what prevents cancer might not treat it.

Chronic inflammation and obesity suppress AMPK activity, creating a negative feedback loop that exacerbates insulin resistance and metabolic disease.

Weight loss and reducing inflammation can help restore normal AMPK activity, which improves metabolic health. Strategies like exercise and calorie restriction are effective because they counteract the suppression of AMPK caused by obesity and chronic inflammation.

Daytime wakefulness is associated with the mobilization of cytotoxic effector cells (NK cells, CTLs) to peripheral blood to provide immediate immunosurveillance against injury or infection.

Acute stress or physical activity during the day naturally mobilizes your 'first responder' immune cells (NK cells) to tissues where they are needed. This is a normal, healthy response to being awake and active.

Mitochondrial dysfunction, characterized by reduced oxidative capacity and increased reactive oxygen species (ROS) production, is a central cause of insulin resistance in skeletal muscle, liver, and adipose tissue.

Focus on improving mitochondrial health through regular physical activity (especially aerobic and resistance training) and managing nutrient quality to reduce oxidative stress, as these factors directly influence insulin sensitivity at the cellular level.

Elevated circulating free fatty acids (FFAs) lead to intracellular lipid accumulation (diacylglycerol and triglycerides) in non-adipose tissues, which activates serine kinases (PKC, IKK, JNK) that phosphorylate IRS proteins, inhibiting insulin signaling and causing insulin resistance.

Managing fat intake and reducing excess calories can lower circulating FFAs, preventing lipid accumulation in muscles and liver, which helps maintain proper insulin signaling.

Very-low-calorie diets (VLCDs) produce larger initial weight losses than conventional low-calorie diets but do not improve long-term weight maintenance outcomes.

Crash diets (600-800 calories) will help you lose weight faster initially, but you will likely regain it faster and end up at the same weight as if you had lost it slowly. For long-term success, avoid extreme restriction and focus on sustainable habits.

Phytochemicals provide health benefits through specific biochemical mechanisms, but efficacy must be demonstrated in vivo, as in vitro and animal studies alone are insufficient to claim disease prevention in humans.

Do not rely on isolated phytochemical supplements to treat or prevent disease based solely on lab studies. While plant compounds like polyphenols and terpenes have known mechanisms (e.g., antioxidant, anti-inflammatory), their actual benefit in humans depends on absorption and metabolism. Focus on whole food sources (fruits, vegetables, grains) rather than isolated extracts, as the synergy and bioavailability in whole foods are better understood than in isolated nutraceuticals.